Skip to main content
. 2024 Nov 19;11:2283–2292. doi: 10.2147/JHC.S491733

Figure 2.

Figure 2

Kaplan–Meier-estimated PFS and OS curves in HCC patients with PM receiving different therapies. (A) PFS before PSM; (B) OS before PSM; (C)PFS after PSM; (D)OS after PSM.

Abbreviations: PFS, progression-free survival; OS, overall survival; HCC, hepatocellular carcinoma; PM, pulmonary metastases; PSM, propensity score matching; HR, hazard ratio; CI, confidence interval; S+L, sintilimab combined with lenvatinib; RT+S+L, radiotherapy combined with sintilimab and lenvatinib.